Veterinary News and Research

RSS

Human ‘common cold’ virus kills healthy chimpanzees in Uganda

In the wild, chimpanzees face any number of dire threats, ranging from poachers to predators to deforestation.

13 Dec 2017

First short-acting ‘follow-on’ insulin receives FDA approval to treat diabetes

The U.S. Food and Drug Administration today approved Admelog (insulin lispro injection), a short-acting insulin indicated to improve control in blood sugar levels in adults and pediatric patients aged 3 years and older with type 1 diabetes mellitus and adults with type 2 diabetes mellitus.

12 Dec 2017

Unique liver function of South American amphibian could pave way for finding a cure to cirrhosis

The unique liver function of a South American amphibian, Siphonops annulatus, could pave the way to finding a cure to the devastating liver condition cirrhosis, a new study published in the prestigious Journal of Anatomy reports.

6 Dec 2017

FDA grants approval to first biosimilar for treatment of patients with breast, stomach cancers

The U.S. Food and Drug Administration today approved Ogivri (trastuzumab-dkst) as a biosimilar to Herceptin (trastuzumab) for the treatment of patients with breast or metastatic stomach cancer (gastric or gastroesophageal junction adenocarcinoma) whose tumors overexpress the HER2 gene (HER2+).

4 Dec 2017

Study identifies new role for stress receptor CRF1 expressed on mast cells

A new study published online in the Journal of Leukocyte Biology provides new insight into how stress, through signaling of corticotropin-releasing factor (CRF), interacts with cells in the immune system to cause disease.

1 Dec 2017

Genetics may affect how the body responds to a particular diet

We can add one more thing to the list of traits affected by genetics: how our bodies respond to a particular diet.

1 Dec 2017

New cancer drug begins clinical trial in human patients with rare brain tumor

A drug that spurs cancer cells to self-destruct has been cleared for use in a clinical trial of patients with anaplastic astrocytoma, a rare malignant brain tumor, and glioblastoma multiforme, an aggressive late-stage cancer of the brain.

28 Nov 2017

Changes in microbiome due to antibiotic exposure may increase risk for inflammatory bowel disease

Exposure to antibiotics in mothers may increase risk for inflammatory bowel diseases in their offspring. This is the finding of a study in mice led by researchers from NYU School of Medicine and published Nov. 27 in the journal Nature Microbiology.

27 Nov 2017

Study demonstrates close relationship between parents' diet and offspring immunity

A review of studies about parents' diet and the immunity of animal offspring has found a close relationship exists, with implications for wildlife conservation and livestock rearing as well as human health.

27 Nov 2017

Flies may be more potent pathogen carriers than previously thought

Flies can be more than pesky picnic crashers, they may be potent pathogen carriers, too, according to an international team of researchers.

25 Nov 2017

Researchers find no signs of early-onset OA in radiographs of Dolly's skeleton

Original concerns that cloning caused early-onset osteoarthritis (OA) in Dolly the sheep are unfounded, say experts at the University of Nottingham and the University of Glasgow.

23 Nov 2017

Leishmania genome study reveals the parasites adaptation to the environment

A new study, conducted by researchers from the Institut Pasteur in Paris and the Centre for Genomic Regulation (CRG) in Barcelona, have revealed that Leishmania adaptation is a consequence of reversible and frequent chromosomal amplifications.

23 Nov 2017

Leishmania adaptation to environmental changes results from frequent chromosomal amplifications

Leishmaniasis is an important human and veterinary disease caused by Leishmania parasites that affect 12 million people in over 98 endemic countries. The disease is now emerging in Europe due to climate change and massive population displacement.

23 Nov 2017

FDA approves first medical device system that can make adjustments to implanted lens after cataract surgery

The U.S. Food and Drug Administration today approved the RxSight Inc. Light Adjustable Lens and Light Delivery Device, the first medical device system that can make small adjustments to the artificial lens' power after cataract surgery so that the patient will have better vision when not using glasses.

22 Nov 2017

FDA approves remote programming feature for Nucleus Cochlear Implant System via telemedicine

The U.S. Food and Drug Administration today approved a remote feature for follow-up programming sessions for the Nucleus Cochlear Implant System through a telemedicine platform.

20 Nov 2017

Scientists identify biomarkers that predict risk of death in Ebola patients

Scientists have identified a set of biomarkers that indicate which patients infected with the Ebola virus are most at risk of dying from the disease.

17 Nov 2017

FDA approves first adjuvant treatment to reduce risk of kidney cancer recurrence

The U.S. Food and Drug Administration today approved Sutent (sunitinib malate) for the adjuvant treatment of adult patients who are at a high risk of kidney cancer (renal cell carcinoma) returning after a kidney has been removed (nephrectomy).

17 Nov 2017

FDA approves new drug to treat bleeding in hemophilia A patients

The U.S. Food and Drug Administration today approved Hemlibra (emicizumab-kxwh) to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients with hemophilia A who have developed antibodies called Factor VIII (FVIII) inhibitors.

17 Nov 2017

FDA permits marketing of first electric stimulation device to reduce opioid withdrawal symptoms

Today, the U.S. Food and Drug Administration granted a new indication to an electric stimulation device for use in helping to reduce the symptoms of opioid withdrawal.

16 Nov 2017

FDA approves drug to treat pediatric, adult patients with rare Sly syndrome

The U.S. Food and Drug Administration today approved Mepsevii (vestronidase alfa-vjbk) to treat pediatric and adult patients with an inherited metabolic condition called mucopolysaccharidosis type VII (MPS VII), also known as Sly syndrome. MPS VII is an extremely rare, progressive condition that affects most tissues and organs.

15 Nov 2017

Veterinary News and Research

Human ‘common cold’ virus kills healthy chimpanzees in Uganda

First short-acting ‘follow-on’ insulin receives FDA approval to treat diabetes

Unique liver function of South American amphibian could pave way for finding a cure to cirrhosis

FDA grants approval to first biosimilar for treatment of patients with breast, stomach cancers

Study identifies new role for stress receptor CRF1 expressed on mast cells

Genetics may affect how the body responds to a particular diet

New cancer drug begins clinical trial in human patients with rare brain tumor

Changes in microbiome due to antibiotic exposure may increase risk for inflammatory bowel disease

Study demonstrates close relationship between parents' diet and offspring immunity

Flies may be more potent pathogen carriers than previously thought

Researchers find no signs of early-onset OA in radiographs of Dolly's skeleton

Leishmania genome study reveals the parasites adaptation to the environment

Leishmania adaptation to environmental changes results from frequent chromosomal amplifications

FDA approves first medical device system that can make adjustments to implanted lens after cataract surgery

FDA approves remote programming feature for Nucleus Cochlear Implant System via telemedicine

Scientists identify biomarkers that predict risk of death in Ebola patients

FDA approves first adjuvant treatment to reduce risk of kidney cancer recurrence

FDA approves new drug to treat bleeding in hemophilia A patients

FDA permits marketing of first electric stimulation device to reduce opioid withdrawal symptoms

FDA approves drug to treat pediatric, adult patients with rare Sly syndrome

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News